Dear Colleagues,

We are excited to invite you to the 3rd edition of the Cardiovascular, Renal, Metabolic, Liver, and Obesity Conference (CaReMeLO – Asia 2026), taking place in New Delhi, India, on 16-18 January 2026.

Following the tremendous success of the second edition of the CaReMeLO conference in Warsaw in 2025, which saw over 1000 participants, we are building on this momentum to further empower family physicians in the comprehensive management of cardiovascular, renal, metabolic, liver and obesity conditions. In 2026, we are proud to announce the expansion of the CaReMeLO conference to Asia, marking a significant milestone in our mission to broaden global collaboration and knowledge-sharing.

This year, we are placing a greater emphasis on cutting-edge therapies, such as the GLP-1R agonist, and the dual GIPR/GLP-1R agonist which are transforming obesity treatment. In addition, we will be highlighting the critical role of vaccination in high-risk populations—an often under-addressed but essential aspect of managing cardiometabolic and liver diseases.

The 2026 edition promises to deliver an even more dynamic and impactful experience, incorporating feedback from last year. Expect more interactive sessions, practical real world case studies, and enriched networking opportunities, as well as deeper explorations of the latest treatments and innovations in managing obesity and liver disease.

This conference is vital for family physicians, general practitioners, nurse practitioners, and specialists in endocrinology, cardiology, and nephrology. If you are involved in managing patients with cardiometabolic and obesity syndromes, this event is designed for you.

Join us in New Delhi to explore innovative strategies and strengthen your expertise in managing CaReMeLO syndromes. This is your opportunity to make a lasting impact on patient care and outcomes. Stay tuned for more details about this essential event for primary care providers and specialists.

We eagerly anticipate welcoming you to CaReMeLO – Asia 2026 in New Delhi!

On behalf of the Scientific Committee,

Prof. Avraham Karasik
Co-Chair of CaReMeLO, Professor of Medicine (Emeritus), Tel Aviv University, Israel

Prof. Dr. Josep Vilaseca
Co-Chair of CaReMeLO, General Practitioner/ Family Doctor, University of Vic – Central Catalonia University; Althaia Foundation, Spain

Dr. Baruch Itzhak
Co-Chair of CaReMeLO, Specialist in Family Medicine, Diabetologist, Clalit Health Services, Technion Faculty of Medicine, Haifa, Israel

Dr. Banshi Saboo
Co-Chair of CaReMeLO, Diabetologist, Dia Care – Diabetes Care & Hormone Clinic, Ahmedabad, India